Technology
MicroStrategy
Industry Life Science
Platform iPad App
CapabilitiesData Storytelling Design Thinking
Anti-epileptic drugs (AEDs) are the main type of treatment for most people with epilepsy. Up to 70% of people could stop having seizures with the right medication. AED’s are preventative medication taken every day to try and stop seizures from happening. The developed app gives a comparison between healthcare utilization and costs in patients treated with long-acting (LA) vs short-acting (SA) Anti-epileptic drug (AED) monotherapy. The report provides insights on drug effectiveness and utilization to provide concrete findings to accelerate the business of pharma companies. Physicists, R&D Professionals, and Scientists in Pharma and Healthcare Domain are the end-users of this application.
Challenges
- Lack of comprehensive study on AED’s on a single platform
- There are over 20 AEDs and each has a particular type or types of seizures that it works for, collating data for different AED’s and linking it with other metrics remained a challenge
- Lack of information about patients concerning demographics, gender, and interlinked comorbidities
- Lack of systematic bifurcation study on long-acting (LA) vs short-acting (SA) anti-epileptic drug (AED)
Solution
Our solution enabled the following capabilities to address customer challenges :
- Interactive and seamless interface that accelerated the decision-making process
- Powerful Insights suggestive of a comprehensive study on AED’s
- Insights into each AED with healthcare costs and healthcare utilization
- Advanced analytics comparing long-acting (LA) vs short-acting (SA) AED’s with respect to demographics, Physician speciality, Healthcare costs,etc.
- Key insights into patients receiving AED’s with extended duration have lower healthcare costs and improved health and economic outcome
Reduced time to Insight
Reduced maintenance and cost ffforts
Increase in informed decision making by patients
Increase in sales margin of AED manufacturers